Daxor corporation streamlines regulatory strategy for groundbreaking diagnostic device

Company to focus on 510(k) approval path, accelerating time-to-market oak ridge, tn, sept. 27, 2024 (globe newswire) -- daxor corporation (nasdaq: dxr), the global leader in blood volume measurement technology, today announces a strategic update to its regulatory approach for its novel diagnostic blood volume analyzer platform.
DXR Ratings Summary
DXR Quant Ranking